Cancer of the breast, ductal carcinoma in situ (dcis) ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 233.0 is one of thousands of ICD-9-CM codes used in healthcare.
Full Answer
Billable Medical Code for Carcinoma In Situ of Breast Diagnosis Code for Reimbursement Claim: ICD-9-CM 233.0. Code will be replaced by October 2015 and relabeled as ICD-10-CM 233.0. The Short Description Is: Ca in situ breast. Known As
Diagnosis Code for Reimbursement Claim: ICD-9-CM 174.9. Code will be replaced by October 2015 and relabeled as ICD-10-CM 174.9. The Short Description Is: Malign neopl breast NOS.
8523/3 Infiltrating duct mixed with other types of carcinoma (C50._) Infiltrating duct and cribriform carcinoma (C50._) Infiltrating duct and mucinous carcinoma (C50._) Infiltrating duct and tubular carcinoma (C50._) Infiltrating duct and colloid carcinoma (C50._) 8524/3 Infiltrating lobular mixed with other types of carcinoma (C50._) Infiltrating lobular mixed with cribriform …
· Infiltrating ductal carcinoma of breast, stage 4; Infiltrating ductal carcinoma of female breast, stage 1; Infiltrating ductal carcinoma of female breast, stage 2; ... Convert C50.919 to ICD-9-CM. Code History. 2016 (effective 10/1/2015): New …
Metastatic Breast Cancer Definition and Symptoms. Metastatic breast cancer is when a cancer begins in the breasts and spread to other parts of the body. This happens because cancer cells break away and enter the blood stream, allowing the cancer to spread. Breast cancer most commonly spreads to the bones but can spread to any part of the body.
Breast cancer most commonly spreads to the bones but can spread to any part of the body . Symptoms of breast cancer are a lump in the breast, chest wall, or armpit, a change in the size of the breast, a dimple or “pucker” in the breast, and discharge or bleeding from the nipple.
For diagnostic terms in the pathology report which are not part of the following list, refer to your ICD-O -3 manual.
Synonyms for carcinoma in situ: noninfiltrating, intraductal, lobular carcinoma in situ, Stage 0, noninvasive, no stromal involvement, papillary intraductal, papillary non infiltrating, intracystic, lobular neoplasia, lobular noninfiltrating, confined to epithelium, intraepithelial, intraepidermal
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C50.919 became effective on October 1, 2021.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C50.912 became effective on October 1, 2021.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...
When tumor is found in one lobe, both lobes or in prostatic apex by needle biopsy but is not palpable or visible by imaging, use code 15. C. CODES 20 to 24 are used only for clinically/radiographically apparent tumor, i.e., that which is palpable or visible by imaging.
The position of the tumor in the breast may be described as the positions on a clock
Duct carcinoma, NOS (8500): The largest group of breast cancers. Duct carcinoma, NOS is not a specific histologic type because it lacks specific features that can be used to better classify the tumor. See Table 1 and Table 2 for intraductal and duct types.
Invasive: A tumor that penetrates beyond the ductal basement membrane into the adjacent stroma of the breast parenchyma.
Carcinoma with osteoclast-like giant cells (8035): This is a specific type of duct carcinoma. The carcinomatous part of the lesion is most commonly an infiltrating duct carcinoma.
1. Code the primary site to C508 when there is a single tumor that overlaps two or more subsites, and the subsite in which the tumor originated is unknown 2. Code the primary site to C508 when there is a single tumor located at the 12, 3, 6, or 9 o’clock position on the breast . 3.
Sarcoma of breast: Primary sarcomas of the breast are rare accounting for less than 0.1% of all malignant tumors of the breast. Diagnoses may include fibrosarcoma, angiosarcoma, pleomorphic sarcoma, leiomyosarcoma, myxofibrosarcoma, hemangio- pericytoma, and osteosarcoma (extra-osseous osteosarcoma of breast).